Willow vs FeelGood Meds: Oral GLP-1 Tracking vs Compounded Care
Quick verdict: Willow emphasizes a telehealth-first oral GLP-1 program built around progress tracking and follow-up, while FeelGood Meds highlights lower-cost compounded injections and tablets plus a branded option; choose based on whether structured digital follow-up or lower starting price and product variety matter more. Willow vs FeelGood Meds frames a tradeoff between support infrastructure and price and formulation options.
Explore Willow’s program and tracking tools
How Willow and FeelGood Meds differ at a glance
This comparison uses only captured evidence. It focuses on the most distinctive differences observed: delivery and support model, pricing and product types, follow-up and tracking emphasis, and regulatory notes about compounded medications. Treatment is available from both only when a licensed clinician determines it is medically appropriate.
1. Delivery model and follow-up
Willow positions itself as a telehealth-first weight management program emphasizing progress tracking tools and follow-up consultations as part of a structured weight management journey rather than a medication subscription. FeelGood Meds advertises clinician-reviewed online treatment options with compounded injections, compounded tablets, and a branded medication option, highlighting no membership fee and free shipping for captured landing-page offers.
See Willow’s telehealth workflow and follow-up
2. Price and product options
Pricing evidence differs. Willow’s captured starting price is 299. FeelGood Meds reports multiple starting prices: compounded injections from $149/month, compounded tablets from $249/month, and a branded option shown from $1,999/month. FeelGood Meds also promotes free shipping in captured landing-page text. Specific renewal terms, total cost, and state availability for FeelGood Meds require confirmation per their captured content.
View FeelGood Meds’ pricing and product options
3. Support, tools and program framing
Willow describes its program as structured to convert GLP-1 efficacy into sustainable long-term outcomes by pairing medication access with behavioral scaffolding, licensed telehealth team oversight, and progress tracking tools. FeelGood Meds emphasizes personalized GLP-1 treatments with multiple product formats and notes a Weight Loss Money Back Guarantee in captured landing-page text. Both state treatment is subject to clinician review.
4. Regulatory and compounded medication notes
Both providers’ captured evidence includes regulatory cautions. Willow notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. FeelGood Meds likewise states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow additionally notes medication-specific approval status must be confirmed; branded and compounded products are not interchangeable.
| Criteria | Willow | FeelGood Meds |
|---|---|---|
| Primary model | Telehealth-first program with progress tracking and follow-up consultations | Clinician-reviewed online treatment with compounded and branded options |
| Starting price (captured) | 299 | Compounded injections from $149/mo; tablets from $249/mo; branded from $1,999/mo |
| Product formats | Oral GLP-1 program (captured as oral) | Compounded injections, compounded tablets, branded option |
| Follow-up and tools | Progress tracking tools and follow-up consultations emphasized | Landing page lists free shipping and no membership fee; follow-up details require confirmation |
| Regulatory note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Direct comparison of what matters most
Support and behavior change: Willow explicitly markets a structured journey with licensed telehealth team support, progress tracking, and follow-up consultations. That emphasis is presented as the core differentiator for people who want a program framed around sustained behavior change.
Price and choice: FeelGood Meds lists lower starting pricing for compounded injections at $149/month and compounded tablets from $249/month, plus a much higher branded option shown from $1,999/month. FeelGood Meds also captured claims of no membership fee and free shipping. Willow’s captured evidence lists a starting price of 299 and notes a higher monthly entry pricing for some plans as a con.
Regulatory clarity: Both suppliers include captured regulatory language warning that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow also flags that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Check FeelGood Meds’ eligibility details and options
Conclusion and who should pick which provider
Willow vs FeelGood Meds shows a clear split: Willow centers on a telehealth program with progress tracking and structured follow-up, while FeelGood Meds centers on lower-cost compounded formats and a branded option with promotional claims captured about free shipping and no membership fee. Both require clinician approval and both include captured regulatory cautions about compounded products.
Choose Willow if you want a telehealth-first program that emphasizes progress tracking, follow-up consultations and a structured weight management journey.
Choose FeelGood Meds if you prioritize lower starting prices for compounded injections or tablets, want a choice that includes a branded option, and will confirm eligibility, renewal terms and state availability before enrolling.